Ptc Therapeutics (PTCT) Return on Sales (2012 - 2026)

Ptc Therapeutics' Return on Sales history runs 15 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales fell 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.02% (down 2.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Ptc Therapeutics, up from 0.08% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2023 to a low of 0.08% in Q4 2025.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
• The sharpest annual moves came in 2023 and 2025: Return on Sales increased 3 bps in 2023, then fell 8 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then soared by 268 bps to 0.02% in 2023, then sank by 119 bps to 0.0% in 2024, then plunged by 1989 bps to 0.08% in 2025, then jumped by 100 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.08% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.